News

12.21.20

EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma

WALTHAM, MA, December 21, 2020 (ACCESSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”), a clinical stage company focused on developing products for treating disorders of the eye,...
11.09.20

EyeGate Pharma Reports Third Quarter 2020 Financial Results and Provides Business Update

WALTHAM, MA, November 9, 2020 – EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”), a clinical-stage company focused on developing products for treating disorders of the eye, today announced...
09.08.20

EyeGate Pharma to Present at H.C. Wainwright 22nd Annual Global Investment Conference

WALTHAM, MA, September 8th, 2020 (ACCESSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”), a clinical-stage company focused on developing products for treating disorders of the eye, announced...
08.12.20

EyeGate Pharma Confirms Path Forward with FDA To Develop Combination Product

WALTHAM, MA, August 12, 2020 (ACCESSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”), a clinical-stage company focused on developing products for treating disorders of the eye, announced...
08.06.20

EyeGate Pharma Reports Second Quarter 2020 Financial Results and Provides Business Update

WALTHAM, MA, August 6, 2020 – EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”), a clinical-stage company focused on developing products for treating disorders of the eye, today announced...
07.14.20

EyeGate Pharma to Proceed with PE Pivotal Study

WALTHAM, MA, July 14, 2020 (ACCESSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”), a clinical-stage company focused on developing products for treating disorders of the eye, announced...
06.11.20

EyeGate Pharma Receives Positive Feedback from FDA Regarding Ocular Bandage Gel Packaging

WALTHAM, MA, June 11, 2020 (ACCESSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”), a clinical-stage company focused on developing products for treating disorders of the eye, announced...
06.01.20

EyeGate Pharma to Present at Jefferies 2020 Virtual Healthcare Conference

WALTHAM, MA, June 1, 2020 (ACCESSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”), a clinical-stage company focused on developing products for treating disorders of the eye, announced...